Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Down 39.5% in November

Takara Bio Inc. (OTCMKTS:TKBIF) saw a significant decline in short interest in November. As of November 30th, there was short interest totalling 16,100 shares, a decline of 39.5% from the November 15th total of 26,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Takara Bio Price Performance

Shares of OTCMKTS TKBIF remained flat at $23.20 during midday trading on Thursday. The stock’s 50-day simple moving average is $23.20 and its two-hundred day simple moving average is $23.20. Takara Bio has a 12 month low of $23.20 and a 12 month high of $23.20.

Takara Bio Company Profile

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.